The global cancer biomarkers market is experiencing significant growth, driven by the rising prevalence of cancer, advancements in technology, and the increasing adoption of personalized medicine. As the demand for early and accurate cancer diagnosis escalates, the market is poised for substantial expansion in the coming years.
The global cancer biomarkers market size was valued at USD 18.94 billion in 2018 and is expected to grow to USD 97.42 billion by 2032, registering a compound annual growth rate (CAGR) of 12.4% over the forecast period.
Get More Information: https://www.fortunebusinessinsights.com/industry-reports/cancer-biomarkers-market-100630
Leading players in the cancer biomarkers industry include: